The Roles of Exosomes As Future Therapeutic Agents and Diagnostic Tools for Glioma

Overview

Journal Front Oncol

Specialty Oncology

Date 2021 Nov 1

PMID 34722277

Citations 17

Authors

Xiaoben Wu

Xingbang Wang

Jing Wang

Yingying Hao

Fang Liu

Xin Wang

Lei Yang

Zhiming Lu

Affiliations

Soon will be listed here.

Abstract

Glioma is a common type of tumor originating in the brain. Glioma develops in the gluey supporting cells (glial cells) that surround and support nerve cells. Exosomes are extracellular vesicles that contain microRNAs, messenger RNA, and proteins. Exosomes are the most prominent mediators of intercellular communication, regulating, instructing, and re-educating their surrounding milieu targeting different organs. As exosomes' diameter is in the nano range, the ability to cross the blood-brain barrier, a crucial obstacle in developing therapeutics against brain diseases, including glioma, makes the exosomes a potential candidate for delivering therapeutic agents for targeting malignant glioma. This review communicates the current knowledge of exosomes' significant roles that make them crucial future therapeutic agents and diagnostic tools for glioma.

Citing Articles

Current Non-Metal Nanoparticle-Based Therapeutic Approaches for Glioblastoma Treatment.

Gawel A, Betkowska A, Gajda E, Godlewska M, Gawel D Biomedicines. 2024; 12(8).

PMID: 39200286 PMC: 11351974. DOI: 10.3390/biomedicines12081822.

Harnessing exosomes as cancer biomarkers in clinical oncology.

Ghosh S, Rajendran R, Mahajan A, Chowdhury A, Bera A, Guha S Cancer Cell Int. 2024; 24(1):278.

PMID: 39113040 PMC: 11308730. DOI: 10.1186/s12935-024-03464-5.

Nanotechnology as a new strategy for the diagnosis and treatment of gliomas.

Lei J, Huang Y, Zhao Y, Zhou Z, Mao L, Liu Y J Cancer. 2024; 15(14):4643-4655.

PMID: 39006067 PMC: 11242339. DOI: 10.7150/jca.96859.

Temozolomide and flavonoids against glioma: from absorption and metabolism to exosomal delivery.

Verma P, Joshi H, Singh T, Sharma B, Sharma U, Ramniwas S Naunyn Schmiedebergs Arch Pharmacol. 2023; 397(1):41-57.

PMID: 37566307 DOI: 10.1007/s00210-023-02660-w.

Exosomes as Novel Diagnostic Biomarkers and Therapeutic Tools in Gliomas.

Skouras P, Gargalionis A, Piperi C Int J Mol Sci. 2023; 24(12).

PMID: 37373314 PMC: 10299187. DOI: 10.3390/ijms241210162.

References

Bu N, Wu H, Sun B, Zhang G, Zhan S, Zhang R . Exosome-loaded dendritic cells elicit tumor-specific CD8+ cytotoxic T cells in patients with glioma. J Neurooncol. 2011; 104(3):659-67. DOI: 10.1007/s11060-011-0537-1. View

Manterola L, Guruceaga E, Gallego Perez-Larraya J, Gonzalez-Huarriz M, Jauregui P, Tejada S . A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool. Neuro Oncol. 2014; 16(4):520-7. PMC: 3956347. DOI: 10.1093/neuonc/not218. View

Elsherbini A, Bieberich E . Ceramide and Exosomes: A Novel Target in Cancer Biology and Therapy. Adv Cancer Res. 2018; 140:121-154. PMC: 6109973. DOI: 10.1016/bs.acr.2018.05.004. View

Thakur A, Qiu G, Xu C, Han X, Yang T, Ng S . Label-free sensing of exosomal MCT1 and CD147 for tracking metabolic reprogramming and malignant progression in glioma. Sci Adv. 2020; 6(26):eaaz6119. PMC: 7319757. DOI: 10.1126/sciadv.aaz6119. View

Thakur A, Sidu R, Zou H, Alam M, Yang M, Lee Y . Inhibition of Glioma Cells' Proliferation by Doxorubicin-Loaded Exosomes via Microfluidics. Int J Nanomedicine. 2020; 15:8331-8343. PMC: 7605152. DOI: 10.2147/IJN.S263956. View

Zhang Y, Liu Y, Liu H, Tang W . Exosomes: biogenesis, biologic function and clinical potential. Cell Biosci. 2019; 9:19. PMC: 6377728. DOI: 10.1186/s13578-019-0282-2. View

Qian M, Wang S, Guo X, Wang J, Zhang Z, Qiu W . Hypoxic glioma-derived exosomes deliver microRNA-1246 to induce M2 macrophage polarization by targeting TERF2IP via the STAT3 and NF-κB pathways. Oncogene. 2019; 39(2):428-442. DOI: 10.1038/s41388-019-0996-y. View

Aqil F, Munagala R, Jeyabalan J, Agrawal A, Gupta R . Exosomes for the Enhanced Tissue Bioavailability and Efficacy of Curcumin. AAPS J. 2017; 19(6):1691-1702. DOI: 10.1208/s12248-017-0154-9. View

Peng G, Yang C, Liu Y, Shen C . miR-25-3p promotes glioma cell proliferation and migration by targeting FBXW7 and DKK3. Exp Ther Med. 2019; 18(1):769-778. PMC: 6566094. DOI: 10.3892/etm.2019.7583. View

10.

de Vrij J, Maas S, Kwappenberg K, Schnoor R, Kleijn A, Dekker L . Glioblastoma-derived extracellular vesicles modify the phenotype of monocytic cells. Int J Cancer. 2015; 137(7):1630-42. DOI: 10.1002/ijc.29521. View

11.

Nan Y, Han L, Zhang A, Wang G, Jia Z, Yang Y . MiRNA-451 plays a role as tumor suppressor in human glioma cells. Brain Res. 2010; 1359:14-21. DOI: 10.1016/j.brainres.2010.08.074. View

12.

Edgar J . Q&A: What are exosomes, exactly?. BMC Biol. 2016; 14:46. PMC: 4906597. DOI: 10.1186/s12915-016-0268-z. View

13.

Jia G, Han Y, An Y, Ding Y, He C, Wang X . NRP-1 targeted and cargo-loaded exosomes facilitate simultaneous imaging and therapy of glioma in vitro and in vivo. Biomaterials. 2018; 178:302-316. DOI: 10.1016/j.biomaterials.2018.06.029. View

14.

Lim M, Xia Y, Bettegowda C, Weller M . Current state of immunotherapy for glioblastoma. Nat Rev Clin Oncol. 2018; 15(7):422-442. DOI: 10.1038/s41571-018-0003-5. View

15.

Cheng J, Meng J, Zhu L, Peng Y . Exosomal noncoding RNAs in Glioma: biological functions and potential clinical applications. Mol Cancer. 2020; 19(1):66. PMC: 7098115. DOI: 10.1186/s12943-020-01189-3. View

16.

Yu L, Gui S, Liu Y, Qiu X, Zhang G, Zhang X . Exosomes derived from microRNA-199a-overexpressing mesenchymal stem cells inhibit glioma progression by down-regulating AGAP2. Aging (Albany NY). 2019; 11(15):5300-5318. PMC: 6710058. DOI: 10.18632/aging.102092. View

17.

Munoz J, Bliss S, Greco S, Ramkissoon S, Ligon K, Rameshwar P . Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell-derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity. Mol Ther Nucleic Acids. 2013; 2:e126. PMC: 4027430. DOI: 10.1038/mtna.2013.60. View

18.

Li Y, Guessous F, Zhang Y, diPierro C, Kefas B, Johnson E . MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res. 2009; 69(19):7569-76. PMC: 2756313. DOI: 10.1158/0008-5472.CAN-09-0529. View

19.

Frankel E, Audhya A . ESCRT-dependent cargo sorting at multivesicular endosomes. Semin Cell Dev Biol. 2017; 74:4-10. PMC: 5803488. DOI: 10.1016/j.semcdb.2017.08.020. View

20.

Zhang Z, Guo X, Guo X, Yu R, Qian M, Wang S . MicroRNA-29a-3p delivery via exosomes derived from engineered human mesenchymal stem cells exerts tumour suppressive effects by inhibiting migration and vasculogenic mimicry in glioma. Aging (Albany NY). 2021; 13(4):5055-5068. PMC: 7950307. DOI: 10.18632/aging.202424. View